Commentary on "Sodium-Glucose Cotransporter-2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation"

J Cardiovasc Electrophysiol. 2025 Aug;36(8):2103-2104. doi: 10.1111/jce.70016. Epub 2025 Jul 15.

Authors

Pouya Tayebi¹, Naghmeh Ziaie¹, Mohammad Barary², Ali Alizadeh Khatir¹, Mostafa Javanian³, Soheil Ebrahimpour³

Affiliations

¹ Clinical Research Development Unit, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
² Student Research Committee, Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

PMID: 40662324
DOI: 10.1111/jce.70016

No abstract available

Publication types

Letter